Response to: Unlock AI-Safe-C score's potential at all levels: Improve methods and overcome barriers

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-02-03 DOI:10.1016/j.jhep.2025.01.035

Huapeng Lin, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Victor de Lédinghen, Seung Up Kim

{"title":"Response to: Unlock AI-Safe-C score's potential at all levels: Improve methods and overcome barriers","authors":"Huapeng Lin, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Victor de Lédinghen, Seung Up Kim","doi":"10.1016/j.jhep.2025.01.035","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Data availability statement (delete if not applicable)</h2>Data and results are available upon reasonable request to the corresponding author.</section></section><section><section><h2>Acknowledgements</h2>No acknowledgements for present study</section></section><section><section><h2>Authors' contributions</h2>Research design (H.L., SU.K.), data acquisition (all authors), data analysis (H.L., TC.Y.), manuscript draft (H.L., TC.Y., VW.W., SU.K.). All authors approved the final version of this manuscript.</section></section><section><section><h2>Financial support</h2>No funding for present study</section></section><section><section><h2>Declaration of Competing Interest</h2>Terry Yip has served as an advisory committee member and speaker at Gilead Sciences.Victor de Lédinghen has been an employee of Echosens since April 2024. This study was conducted while he was a Professor of Hepatology at Bordeaux University Hospital(France).Vincent Wong has served as a consultant or advisory board member for AbbVie, Boehringer Ingelheim, Echosens, Intercept, Inventiva, Novo Nordisk, Pfizer, andTARGET PharmaSolutions and a speaker for Abbott, AbbVie, Gilead Sciences, andNovo</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"96 5 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.01.035","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Data availability statement (delete if not applicable)

Data and results are available upon reasonable request to the corresponding author.

Acknowledgements

No acknowledgements for present study

Authors' contributions

Research design (H.L., SU.K.), data acquisition (all authors), data analysis (H.L., TC.Y.), manuscript draft (H.L., TC.Y., VW.W., SU.K.). All authors approved the final version of this manuscript.

Financial support

No funding for present study

Declaration of Competing Interest

Terry Yip has served as an advisory committee member and speaker at Gilead Sciences.Victor de Lédinghen has been an employee of Echosens since April 2024. This study was conducted while he was a Professor of Hepatology at Bordeaux University Hospital(France).Vincent Wong has served as a consultant or advisory board member for AbbVie, Boehringer Ingelheim, Echosens, Intercept, Inventiva, Novo Nordisk, Pfizer, andTARGET PharmaSolutions and a speaker for Abbott, AbbVie, Gilead Sciences, andNovo

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.